M. Tsukamoto

发表

Anti‐endothelial cell antibodies to the endothelial hybridoma cell line (EAhy926) in systemic lupus erythematosus patients with antiphospholipid antibodies

J. Matsuda, M. Gotoh, K. Gohchi, 1997, British journal of haematology.

Inhibitory activity of anti‐β2‐glycoprotein I antibody on factor va degradation by activated‐protein C and its cofactor protein S

J. Matsuda, M. Gotoh, K. Gohchi, 1995 .

Plasma concentrations of total/free and functional protein S are not decreased in systemic lupus erythematosus patients with lupus anticoagulant and/or antiphospholipid antibodies

J. Matsuda, M. Gotoh, K. Gohchi, 1994, Annals of Hematology.

Low serum lipoprotein(a) and β2-glycoprotein I levels in HIV-1-positive hemophiliacs

J. Matsuda, M. Gotoh, K. Gohchi, 1994, Annals of Hematology.

High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha.

J. Matsuda, M. Gotoh, K. Gohchi, 1995, The American journal of gastroenterology.

Resistance to activated protein C activity of an anti‐/2 ‐glycoprotein I antibody in the presence of β‐glycoprotein I

J. Matsuda, M. Gotoh, K. Gohchi, 1995 .

Resistance to activated protein C in systemic lupus erythematosus patients with antiphospholipid antibodies

J. Matsuda, M. Gotoh, K. Gohchi, 1994, European journal of haematology.

Serum lipoprotein(a) level is increased in patients with systemic lupus erythematosus irrespective of positivity of antiphospholipid antibodies.

J. Matsuda, M. Gotoh, K. Gohchi, 1994, Thrombosis research.

Anti-annexin antibody in the sera of patients with habitual fetal loss or preeclampsia.

J. Matsuda, M. Gotoh, K. Gohchi, 1994, Thrombosis research.

Negligible synergistic effect of β2‐glycoprotein I on the reactivity of antioxidized low‐density lipoprotein antibody to oxidized low‐density lipoprotein

J. Matsuda, M. Gotoh, K. Gohchi, 1996, American journal of hematology.

Distinguishing β2‐glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibody with Tween 20

J. Matsuda, M. Gotoh, K. Gohchi, 1993, British journal of haematology.

β2-glycoprotein I -dependent and -independent anticardiolipin antibody in patients with end-stage renal disease

J. Matsuda, K. Gohchi, M. Tsukamoto, 1993 .

Absence of an association between antibodies to retroviral proteins and anticardiolipin antibody and/or lupus anticoagulant in systemic lupus erythematosus.

J. Matsuda, M. Gotoh, K. Gohchi, 1994, Annals of the rheumatic diseases.

In vitro lupus anticoagulant neutralizing activity of intravenous immunoglobulin.

J. Matsuda, K. Gohchi, K. Kawasugi, 1993, Thrombosis research.

Measurement of β2‐glycoprotein i (apolipoprotein h)‐independent anticardiolipin antibody in human immunodeficiency virus‐1‐positive and‐negative hemophiliacs

J. Matsuda, K. Gohchi, M. Tsukamoto, 1993, American journal of hematology.

Hepatitis C virus (HCV) RNA and human immunodeficiency virus (HIV) p24 antigen in the cryoglobulin of hemophiliacs with HIV and/or HCV infection.

J. Matsuda, M. Gotoh, K. Gohchi, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical significance of serum 2,5-oligoadenylate synthetase and soluble interleukin-2 receptor in hemophiliacs positive and negative for human immunodeficiency virus type 1.

J. Matsuda, M. Gotoh, K. Gohchi, 1994, Clinical and diagnostic laboratory immunology.

Low β2‐glycoprotein I levels in patients with disseminated intravascular coagulation

J. Matsuda, M. Tsukamoto, N. Saitoh, 1993 .

Serum adenosine deaminase 2 and neopterin levels are increased in a majority of hemophiliacs irrespective of infection with human immunodeficiency virus type 1.

J. Matsuda, K. Gohchi, K. Kawasugi, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Anticoagulant activity of an anti-beta 2-glycoprotein I antibody is dependent on the presence of beta 2-glycoprotein I.

J. Matsuda, K. Gohchi, M. Tsukamoto, 1993, American journal of hematology.

Detection of beta-2-glycoprotein-I-dependent antiphospholipid antibodies and anti-beta-2-glycoprotein-I antibody in patients with systemic lupus erythematosus and in patients with syphilis.

J. Matsuda, M. Gotoh, K. Gohchi, 1994, International archives of allergy and immunology.

Absence of anticardiolipin antibody in non-treated and heat-inactivated normal human sera.

J. Matsuda, K. Gohchi, M. Tsukamoto, 1992, Thrombosis research.

Prevalence of beta 2-glycoprotein I antibody in systemic lupus erythematosus patients with beta 2-glycoprotein I dependent antiphospholipid antibodies.

J. Matsuda, M. Gotoh, K. Gohchi, 1995, Annals of the Rheumatic Diseases.

Buffer may be the critical factor in measurement of anti‐prothrombin antibody on a γ‐ray‐irradiated plate by enzyme‐linked immunosorbent assay

J. Matsuda, M. Gotoh, M. Tsukamoto, 1996, American journal of hematology.

SHORT REPORT PHOSPHATTDYL SERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODY IS EXCLUSIVE TO PATIENTS WITH LUPUS ANTICOAGULANT

J. Matsuda, M. Gotoh, K. Gohchi, 1996 .

Anticoagulant activity of an anti‐β2‐glycoprotein I antibody is depentent on the presence of β2‐glycoprotein I

J. Matsuda, K. Gohchi, M. Tsukamoto, 1993 .

Effect of total-body cold exposure on plasma concentrations of von Willebrand factor, endothelin-1 and thrombomodulin in systemic lupus erythematosus patients with or without Raynaud's phenomenon.

J. Matsuda, K. Gohchi, M. Tsukamoto, 1992, Acta haematologica.

Phosphatidyl serine-dependent antiprothrombin antibody is exclusive to patients with lupus anticoagulant.

J. Matsuda, M. Gotoh, K. Gohchi, 1996, British journal of rheumatology.

beta 2-Glycoprotein I-dependent and-independent anticardiolipin antibody in patients with end-stage renal disease.

J. Matsuda, K. Gohchi, M. Tsukamoto, 1993, Thrombosis research.

Low beta 2-glycoprotein I levels in patients with disseminated intravascular coagulation.

J. Matsuda, M. Tsukamoto, N. Saitoh, 1993, American journal of hematology/oncology.